Sunflower Pharmaceutical Group Co., Ltd. (002737.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Sunflower Pharmaceutical Group Co., Ltd.
—
Sunflower Pharmaceutical Group Co., Ltd. is led by CEO Yi Guan, employs 5,025 people, headquartered in Harbin, CN, publicly traded since 2014.
Sunflower Pharmaceutical Group Co., Ltd. (002737.SZ) stock trades at $11.20 with a market capitalization of $6.91B. The stock is valued at a negative price-to-earnings (P/E) ratio of -26.77, reflecting a net loss over the last twelve months, price-to-book of 1.68, price-to-sales of 2.76. Over the past 52 weeks the stock has ranged between $11.04 and $15.66, and currently trades 28.5% below its 52-week high. It pays a dividend yielding 1.70%.
On profitability, Sunflower Pharmaceutical Group Co., Ltd. generates a return on equity (ROE) of -6.70% (negative, reflecting a net loss), an operating margin of -3.87%, a net profit margin of -10.36%.
Official website: www.kuihuayaoye.com
Sunflower Pharmaceutical Group Co., Ltd. (002737.SZ) — frequently asked questions
What is Sunflower Pharmaceutical Group Co., Ltd. (002737.SZ) stock price today?
Sunflower Pharmaceutical Group Co., Ltd. (002737.SZ) is currently trading at $11.20, up 0.27% today.
What is 002737.SZ P/E ratio?
Sunflower Pharmaceutical Group Co., Ltd.'s P/E ratio is -26.77. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 002737.SZ return on equity (ROE)?
Sunflower Pharmaceutical Group Co., Ltd.'s return on equity (ROE) is -6.70%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Sunflower Pharmaceutical Group Co., Ltd.'s market cap?
Sunflower Pharmaceutical Group Co., Ltd. has a market capitalization of $6.91B.
Does 002737.SZ pay a dividend?
Yes. Sunflower Pharmaceutical Group Co., Ltd. currently yields 1.70%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 002737.SZ carry?
Sunflower Pharmaceutical Group Co., Ltd. has a debt-to-equity ratio of 0.05. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 002737.SZ's profit margin?
Sunflower Pharmaceutical Group Co., Ltd. reports a net profit margin of -10.36% — the share of revenue left after every cost, including tax and interest.
What sector is 002737.SZ in?
Sunflower Pharmaceutical Group Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 002737.SZ listed on?
Sunflower Pharmaceutical Group Co., Ltd. trades on SHZ under the ticker 002737.SZ.
What is 002737.SZ's 52-week range?
Over the last year Sunflower Pharmaceutical Group Co., Ltd. has traded between $11.04 and $15.66.
Related — Stocks
Popular Stocks
Screens 002737.SZ currently matches
On the figures above, Sunflower Pharmaceutical Group Co., Ltd. passes the filters for 7 of our ready-made screens, among them Dividend Stocks, Low Debt Stocks, Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.